CVRX

CVRx, Inc.
—

Company Information

Company Name
CVRx, Inc.
CIK
CIK0001235912
Category
<br>Emerging growth company
Ticker: Exchange
CVRX: Nasdaq
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
3841
SIC Description
Surgical & Medical Instruments & Apparatus
Ticker
CVRX

SEC filing data through

Insider Sentiment

Last purchase
2026-08-13
Last sale
2026-08-12
Shares purchased (TTM)
73,623
Shares sold (TTM)
33,400
Buy ratio (TTM)68.8%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
15,045,674
Shares outstanding
26,515,442
Ownership
56.74%
+2.79% Y/Y

Earnings Market Reaction

Filing date
2026-08-06
Price on filing date
—
1-month reaction
-50.34%
3-month reaction
…
Drift continued8/11 (73%)
Faded / reversed3/11 (27%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value657276859510310610070809183
Accounts Receivable Net Current9911879999886
Inventory Net131212111212121211111111
Prepaid Expense And Other Assets Current233323332333
Assets Current899710210811612613012492102112104
Property Plant And Equipment Net222222333322
Operating Lease Right Of Use Asset111111111111
Other Assets Noncurrent000000000000
Assets9210010511112013013312896106115106
Liabilities Current
Accounts Payable Current434433334321
Accrued Liabilities Current769876886666
Liabilities Current119131110911119887
Long Term Debt Noncurrent595850494949494929292914
Operating Lease Liability Noncurrent011111111111
Other Liabilities Noncurrent222222111111
Liabilities727165636260626241403924
Stockholders Equity
Common Stock Value000000000000
Additional Paid In Capital Common Stock638633630627624620608592569566553551
Retained Earnings Accumulated Deficit-618-604-591-579-566-551-537-527-514-500-477-468
Accumulated Other Comprehensive Income Loss Net Of Tax-0-0-0-0-0-0-0-0-0-0-0-0
Stockholders Equity202939485869716555667683
Liabilities And Stockholders Equity9210010511112013013312896106115106
Allowance For Doubtful Accounts Receivable Current111111111111
Common Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized200200200200200200200200200200200200
Common Stock Shares Issued272626262626252422222121
Shares Outstanding272626262626252422222121

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

CVRx, Inc. (CVRX) — SEC Financial Statements & Analysis

CVRx, Inc. (CVRX) is a surgical & medical instruments & apparatus company, incorporated in DE. CVRx, Inc. trades on Nasdaq as: CVRX. CVRx, Inc. (CVRX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, CVRx, Inc. carries a market cap of $136.29M, a P/E ratio of -2.62x, a P/B ratio of 6.83x, a P/S ratio of 2.23x, an enterprise value of $130.27M, and an EV/EBITDA multiple of -2.72x. On profitability, it posts a gross margin of 86.92%, an operating margin of -79.49%, a net margin of -84.93%, a Return on Equity (ROE) of -133.44%, a Return on Assets (ROA) of -49.06%, and a Return on Invested Capital (ROIC) of -340.64%. Per share, it reports EPS of $-1.96, diluted EPS of $-1.96, free cash flow per share of $-1.55, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 11.96% year-over-year, net income growth of -0.54% year-over-year, and EPS growth of -2.21% year-over-year. On the balance sheet, it maintains a current ratio of 8.04x, a quick ratio of 6.65x, working capital of $78.36M, a debt-to-equity ratio of 3.63x, a debt ratio of 0.78, an interest coverage ratio of -8.07x, free cash flow of $-41.05M (TTM), and net debt of $-6.01M. Figures sourced from SEC EDGAR.

Market Cap
$136.29M
P/E TTM
-2.62x
EPS TTM
$-1.96
P/B TTM
6.83x
ROE TTM
-133.44%
ROA TTM
-49.06%
Debt To Equity
3.63x
Free Cash Flow TTM
$-41.05M
Net Revenue TTM Growth 1Y
11.96%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CVRx, Inc. in?

CVRx, Inc. (CVRX) operates in the Surgical & Medical Instruments & Apparatus industry.

What exchange does CVRX trade on?

CVRx, Inc. (CVRX) trades on the Nasdaq.

Where is CVRx, Inc. incorporated?

CVRx, Inc. is incorporated in DE.

When was CVRx, Inc. (CVRX)'s most recent SEC filing?

CVRx, Inc. (CVRX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.

What is CVRX's market cap?

CVRx, Inc. (CVRX) has a market capitalization of $136.29M as of 2026-06-30.

What is CVRX's EPS (earnings per share)?

CVRx, Inc. (CVRX)'s trailing twelve month EPS is $-1.96 as of 2026-06-30.

What is CVRX's ROE (return on equity)?

CVRx, Inc. (CVRX)'s trailing twelve month Return on Equity (ROE) is -133.44% as of 2026-06-30.

What is CVRX's ROA (return on assets)?

CVRx, Inc. (CVRX)'s trailing twelve month Return on Assets (ROA) is -49.06% as of 2026-06-30.

What is CVRX's ROIC (return on invested capital)?

CVRx, Inc. (CVRX)'s trailing twelve month Return on Invested Capital (ROIC) is -340.64% as of 2026-06-30.

What is CVRX's EV/EBITDA?

CVRx, Inc. (CVRX)'s trailing twelve month EV/EBITDA is -2.72x as of 2026-06-30.

Wall Street's data.
Main Street's price.